Scarica l'app Stockscreener
3.42
1.44%
-0.05
Dopo l'orario di chiusura:
3.42
Precedente Chiudi:
$3.47
Aprire:
$3.47
Volume 24 ore:
61,490
Relative Volume:
0.07
Capitalizzazione di mercato:
$3.09M
Reddito:
$8.97M
Utile/perdita netta:
$-15.21M
Rapporto P/E:
-0.0294
EPS:
-116.51
Flusso di cassa netto:
$-10.84M
1 W Prestazione:
-3.66%
1M Prestazione:
-17.19%
6M Prestazione:
+283.41%
1 anno Prestazione:
+144.29%
Intervallo 1D:
$3.41
$3.50
Intervallo di 1 settimana:
$3.28
$3.6994
Portata 52W:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Nome
Nuwellis Inc
Settore
Industria
Telefono
952-345-4200
Indirizzo
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Confronta NUWE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
3.42 | 3.13M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
127.63 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.04 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.65 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | ROTH MKM | Buy |
Nuwellis Inc Borsa (NUWE) Ultime notizie
Real time social sentiment graph for Nuwellis Inc.July 2025 Breakouts & Technical Buy Zone Confirmations - newser.com
How sentiment analysis helps forecast Nuwellis Inc.Product Launch & Technical Buy Zone Confirmation - newser.com
Analyzing net buyer seller activity in Nuwellis Inc.Analyst Downgrade & Daily Price Action Insights - newser.com
Visual analytics tools that track Nuwellis Inc. performanceJuly 2025 Patterns & Community Consensus Trade Alerts - newser.com
Is Nuwellis Inc. stock a good choice for value investorsJuly 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com
Combining machine learning predictions for Nuwellis Inc.July 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
Should you wait for a breakout in Nuwellis Inc.M&A Rumor & AI Driven Price Forecasts - newser.com
Momentum divergence signals in Nuwellis Inc. chartJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - newser.com
Is Nuwellis Inc. reversing from oversold territoryDollar Strength & High Yield Equity Trading Tips - newser.com
Key resistance and support levels for Nuwellis Inc.Short Setup & Weekly Market Pulse Updates - newser.com
Will Nuwellis Inc. stock go up soonWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Nuwellis Appoints John L. Erb as Interim CFO - The Globe and Mail
Why Nuwellis Inc. is moving todayWeekly Trade Report & High Yield Equity Trading Tips - newser.com
NuwellisRobert B. Scott resigns as CFO of Nuwellis - MarketScreener
Nuwellis, Inc. Announces Executive Appointments, Effective October 24, 2025 - MarketScreener
Nuwellis Receives NIH Grant to Advance its Pediatric CRRT Platform - Medical Product Outsourcing
Nuwellis Inc Stock Analysis and ForecastInsider Trading Activity & Outperform the Market with Aggressive Picks - earlytimes.in
What drives Nuwellis Inc stock priceSector-Based Investing & Small Investment Trading Plans - earlytimes.in
Tools to assess Nuwellis Inc.’s risk profilePortfolio Value Report & Real-Time Market Trend Scan - newser.com
How interest rate cuts could boost Nuwellis Inc. stock2025 Growth vs Value & AI Enhanced Trading Signals - newser.com
Can technical indicators confirm Nuwellis Inc.’s reversalMarket Risk Summary & Growth Focused Investment Plans - newser.com
What momentum shifts mean for Nuwellis Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com
Using RSI to spot recovery in Nuwellis Inc.Trade Risk Report & Verified Technical Signals - newser.com
Nuwellis Announces ULTRA-Peds Registry Findings - TipRanks
Nuwellis announces findings from ULTRA-Peds registry on Aquadex System use By Investing.com - Investing.com South Africa
Nuwellis announces findings from ULTRA-Peds registry on Aquadex System use - Investing.com
Nuwellis reports 92% survival rate in pediatric Aquadex therapy study - Investing.com
Nuwellis reports 92% survival rate in pediatric Aquadex therapy study By Investing.com - Investing.com South Africa
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex® - The Manila Times
Nuwellis, Inc. Announces Positive Findings from ULTRA-Peds Registry on Aquadex Therapy for Critically Ill Children - Quiver Quantitative
How moving averages guide Nuwellis Inc. tradingProfit Target & AI Based Trade Execution Alerts - newser.com
Is Nuwellis Inc. showing signs of accumulation2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Detecting support and resistance levels for Nuwellis Inc.Gap Down & Comprehensive Market Scan Reports - newser.com
Nuwellis Inc Azioni (NUWE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):